Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Pathological Features of C3 Dominant Glomerulonephritis Among Egyptian Population

NCT06126471 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06126471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Pathological Features of C3 Dominant Glomerulonephritis Among Egyptian Population
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2023
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c3 nephropathy